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Human immunology is entering the next
frontier. With the fast developing tech-
nology, we can today sequence the whole
genome from an individual in a relatively
short time. It is now possible to decipher
pathological mechanisms in immunologi-
cal diseases, including primary immunod-
eficiencies, with high specificity. A particu-
larly interesting aspect to study is the devel-
opment and maintenance of the immune
repertoire diversity and its consequences
for disease progression. Until recently, a
major difficulty in analysis of peripheral
blood cells has been to sequence the locus
encoding the T cell receptor (TCR) and
the B cell receptor (BCR) in each cell.
These receptors are assembled from a large
array of V, (D), and J gene segments in a
process that inserts and deletes nucleotides
in the V(D)J junctions (Figures 1A,B). The
antigenic specificity of the BCR and TCR
is determined by the complementarity-
determining regions (CDR) 1–3, where the
CDR3 covers the junctions between the V,
(D), and J segments and is the most vari-
able part of the receptor (Figures 1A,B). To
add to the complexity, B cells undergo fur-
ther gene diversification in the peripheral
germinal centers by class switch recombi-
nation and induction of somatic hypermu-
tations.
Mutations in the Wiskott–Aldrich
syndrome protein (WASp) cause the
severe immunodeficiency disease Wiskott–
Aldrich syndrome (WAS) (1, 2). WAS has
been associated with numerous cellular
defects and is termed a cell-trafficking
disease of the immune system. WAS−/− B
cells are hyperactive and induce an autore-
active response, whereas WAS−/− T cells
are hyporesponsive and WAS−/− T reg-
ulatory cells fail to suppress effector T
cells (1, 2). Based on the important role
of WASp for peripheral function, it has
been somehow surprising that B and T
cell development is intact as evident in
normal progression through maturation
stages in the bone marrow and thymus,
respectively (2, 3). The role of WASp in
creating a diverse BCR and TCR reper-
toire has until recently remained unknown.
Since a skewed and oligoclonal BCR and
TCR repertoire is linked to autoimmu-
nity (2), a number of laboratories have
now addressed the immune receptor reper-
toire in WAS patients. Two recent studies
show that B cells from WAS patients have
a decreased BCR repertoire, altered V gene
usage, and decreased somatic hypermuta-
tion (4, 5). In T cells, Wada et al. showed
already in 2005 that the TCRVβ reper-
toire was skewed in WAS patients older
than 15 years, while younger WAS patients
showed no repertoire skewing (6). This
year, Braun et al. and Wu et al. showed
that also young WAS patients often had a
skewed TCRVβ repertoire (7, 8).
O’Connell and colleagues (9) have in
the present investigation examined the
BCR and TCR repertoire in WAS patients
using next generation sequencing [NGS,
see recent reviews in Ref. (10, 11)]. Using
this technique, the authors collected a
vast amount of data that allowed them
to analyze the diversity of the receptor
repertoire, including V(D)J segment usage,
CDR3 size distribution, clonal expansions,
and for BCRs; class switch recombina-
tion and frequency of somatic hypermu-
tations. In B cells from WAS patients, the
repertoire diversity tended to be lower
than in controls, and the usage of some
V heavy chain (VH) gene segments was
skewed. However, WAS B cells had nor-
mal rate of somatic hypermutation. In
T cells of WAS patients, clonal expan-
sions were present in the memory CD4+
T cells and both in naïve and mem-
ory CD8+ T cells. The usage of TCRVβ
gene segments tended to be skewed to
a higher extent in WAS patient CD8+
T cells than in WAS patient CD4+ T
cells. These results provide valuable infor-
mation regarding the development and
maintenance of the immune repertoire in
WAS and importantly, describes alterations
mainly in CD8+ T cells.
Interestingly, one out of the three
patients in the study by O’Connell et al.
showed increased VH4–34 expression that
recognizes self-antigens (12). Two other
recent studies have examined the BCR
diversification in WAS patient B cells and
also found overrepresentation of the VH4–
34 gene (4, 5). This suggests that autoreac-
tive B cells are expanded in WAS patients,
and the current study indicates that these
B cells may be present even before clin-
ical signs of autoimmune disease. Simon
et al. and Castiello et al. describe decreased
somatic hypermutation in WAS patients
Abbreviations: C, constant; CDR, complementary determining region; D, diversity; J, joining; N, non-templated; V, variable; WAS, Wiskott–Aldrich syndrome; WT,
wildtype.
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FIGURE 1 | Spectratyping analysis ofTCRVβ repertoire inWT and
WAS−/− mice. (A) Schematic of the TCR structure. The TCR is composed
of an α and a β chain and the CDR3 regions determine most of the
antigenic specificity. (B) V(D)J recombination results in varying CDR3
lengths. The size of the CDR3 region, comprising the segment junctions
with a variable number of non-templated (N) nucleotides, differs between
cells. (C) Spectratyping analysis. PCR products using TCRVβ specific
primers (FWD) together with a Cβ primer (REV) were separated with
capillary electrophoresis and analyzed for CDR3 transcript lengths using
Peak Scanner™ Software v2.0. Each peak represents all cells expressing
the same CDR3 length. In the healthy naïve T cell population, the CDR3
size distribution is Gaussian. (D)The thymocyte TCRVβ repertoires in one
WT and one WAS−/− mouse at 7 months of age. (E) Quantification of
CDR3 size distribution. Non-linear regression analysis was performed on
spectratyping data. An R2 value of 1 indicates a perfect Gaussian
distribution. (F)TCRVβ–CDR3 size distribution in thymus and spleen of
three WT and three WAS−/− mice at 7 months of age. R2 values with
mean±SEM. **P =0.0013.
while the three patients in the O’Connell
study showed normal somatic hypermuta-
tion. This may reflect differences in clin-
ical status of the patients both in regards
to infections and presence of autoim-
mune disease. In the T cell compartment,
Wada et al. used the classical technique
of CDR3-spectratyping (Figure 1C) and
showed a skewed TCRVβ repertoire in
WAS patients over 15 years of age, while
younger patients showed a normal TCRVβ
repertoire. These results suggested that
thymic diversification may be intact. The
authors reasoned that the oligoclonal TCR
repertoire could reflect accumulation of
T cell clones specific to autoantigens or
result from chronic infections (6). How-
ever, using the same technique, Braun
et al. recently showed that even young
WAS patients often had a skewed TCRVβ
repertoire (7). The work by O’Connell et al.
extends these studies by usage of NGS on
sorted T cell subsets and identifies restric-
tion in the TCRVβ repertoire mainly in
CD8+ T cells from young WAS patients.
A recently published study supports this
finding and shows that WAS mutations in
young patients differentially influence the
TCR diversity of different T cell subsets as
determined by both CDR3-spectratyping
and NGS. Compared with age-matched
healthy control subjects, TCR diversity of
WAS patient cells was severely skewed
in memory/effector CD4+CD45RO+ T
cells and CD8+CD45RA+CCR7− TEMRA
cells (13).
A limitation of the CDR3-spectratyping
(Figure 1C) is that unique sequences are
not identified. As a result, it is not possi-
ble to distinguish if a peak in the spectrum
represents many unique sequences of iden-
tical length or one clonally expanded
TCR. The highly detailed data output
obtained from NGS enables intricate analy-
ses regarding the relationship between
unique sequences and total sequences.
O’Connell et al. show that WAS patients
have reduced diversity of unique BCR
and TCR sequences, indicating decreased
capacity to diversify the receptor repertoire
in the bone marrow and thymus, respec-
tively. As the authors discuss, reduced
diversity of unique sequences may also
reflect decreased survival of B and T cells
in the peripheral organs. Another explana-
tion may be that NGS do not yet provide
full sequence coverage and that underrep-
resented BCR and TCRs are excluded.
In all studies of WAS patients, it is diffi-
cult to fully define the cause for disturbed
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BCR and TCR repertoires. The repertoire
may show alterations due to aberrant devel-
opment, exposure to chronic infections
(that may vary with age and in differ-
ent countries), and/or autoimmune dis-
ease commonly seen in older WAS patients.
In patients, addressing these interesting
aspects would require analysis of new-
borns with a family history of disease. In
an attempt to investigate age-related alter-
ations in thymic output and to exclude
potential burden of infections, we exam-
ined the TCRVβ repertoire in thymus and
spleen of 4 weeks young and 7 months old
WAS−/−mice housed in specific pathogen-
free condition. In young WAS−/−mice, the
TCRVβ repertoire was indistinguishable to
littermates controls and showed a Gauss-
ian distribution reflecting the diverse TCR
repertoire (unpublished data). In old mice,
the TCRVβ repertoire of WAS−/− mice
showed more aberrations from the Gauss-
ian distribution as compared to littermate
control mice, both in thymus and spleen
(Figures 1D–F). Our data suggest that in
the absence of infections, autoantigens is
the likely trigger of deviations from the
diverse TCR repertoire in old mice. More-
over, the reduced TCRVβ repertoire diver-
sity in thymocytes of old WAS−/− mice
support the notion raised by O’Connell
et al. and Park et al. that thymic output
is impaired in WAS (14).
Using NGS, valuable insights can be
made in the study of the immune repertoire
in human diseases such as WAS. The work
by O’Connell and colleagues raises a num-
ber of intriguing questions, most impor-
tantly, how do relatively small changes
in the BCR and TCR repertoire lead to
severe disturbances in functionality of B
and T cells? WAS−/− B cells are intrinsi-
cally hyperactive and have increased home-
ostatic expansion in the periphery (15).
This together with an altered BCR reper-
toire as shown in the present study and
in previous studies (4, 5), suggests that B
cells drive autoimmune disease in WAS.
O’Connell et al. show that memory CD4+
T cells have a limited TCR repertoire and
it has previously been shown that WAS−/−
CD4+ T cells can drive autoimmune colitis
(16). The present study raises the intriguing
possibility that also CD8+ T cells may be
autoreactive with a limited TCR repertoire
as is often seen in diseases with disturbed
thymopoiesis such as Omenn syndrome
(17). How this is related to previous find-
ings of decreased cytotoxic capacity and
reduced IFNγ production by WAS CD8+
T cells remains to be determined (18).
Decreased production of IFNγ is charac-
teristic of TEMRA cells, a subset of CD8+ T
cells that are terminally differentiated and
functionally exhausted (19). TEMRA cells
are expanded upon chronic viral infection,
a common clinical complication in WAS
patients. It is possible that the restricted
TCR repertoire of CD8+ T cells in WAS
patients to a large extent is represented by
an expansion of TEMRA cells as shown in
the present study by O’Connell et al. and in
the recent paper by Wu et al. (9, 13).
What are the future challenges for NGS?
An important question is to determine
if peripheral blood lymphocytes repre-
sent B and T cells in tissues such as the
spleen, lymph node, skin, and the gut.
Peripheral blood B cells may represent as
little as 2% of the body’s total B cells
(11). A recent study raises the intrigu-
ing possibility that B cell development
occurs at sites in the intestinal mucosa
and strikingly, that the gut BCR repertoire
is vastly different from the repertoire in
the bone marrow (20). This suggests that
the commensal microbes influence anti-
body diversification in the gut and that
this may be an important aspect to con-
sider in analysis of peripheral blood from
patients. NGS is superior to all previous
approaches in the coverage of sequences.
Nevertheless, the number of unique BCR
and TCR sequences by far exceeds the
number of sequences obtained by NGS
(normally 104–105 sequences as in the
O’Connell study). Thus, with the current
technology it may still prove difficult to
obtain full coverage of the BCR and TCR
repertoire. Another limitation is the repro-
ducibility when analyzing rare sequences
using alternative sequencing platforms. In
one study, blood samples from the same
donor were analyzed in parallel on the 454,
Illumina, and Ion Torrent sequencing plat-
forms (21). Profound discrepancies were
revealed, with the three datasets differing
significantly in terms of the diversity and
relative abundance of clones within the
overall repertoire.
This study identifies TCRs and BCRs
that are clonally expanded in WAS patients.
The next challenge is to identify the antigen
recognized by a particular receptor. For B
cells, Wardemann et al. described already
in 2003 the method of single cell cloning
and antibody expression to demonstrate
that a large proportion of newly generated
B cells in fact express self- and poly-reactive
BCRs (22). This method has been particu-
larly useful in identification of self-antigens
in autoimmune disease. Antigen recogni-
tion by TCRs is more complex since TCRs
can only recognize antigenic peptides pre-
sented by MHC molecules by numerous
unpredictable contacts (10). To identify
the antigen recognition by a cloned TCR,
the TCR can be screened over a library
of MHC-peptides in insect cells or yeast
cells. By comparing the identified antigenic
peptide to candidate antigens in disease,
the pathological peptide can be identified
successfully (23).
In conclusion, the present study begins
to unravel the BCR and TCR repertoire
in WAS patients and paves the road for a
better understanding of the differences in
response to treatment such as bone mar-
row transplantation and gene therapy, the
latter currently in clinical trial (5, 7, 24).
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